.jpg)
About this webinar
The design, make, test, and analyze cycle (DMTA), which drives early-stage drug discovery, requires workflows and automated methods for sample storage and tracking, low volume dispensing of assay-ready plates, analysis and interpretation. Due to the expense and infrastructure required for accurate and efficient sample management, including space requirements, automation, and IT support, at smaller biotech companies this is commonly outsourced to contract research organizations.
In this webinar, learn how the team at Artios Pharma have developed and implemented automated end-to-end workflows for sample storage and tracking, processing, assay-ready plate generation and sample mapping for analysis, using Titian Sample Bank software and SPT Labtech automation systems. Using this compound management workflow, they have demonstrated up to a 40% reduction in data posting cycle times and decreased running costs, as well as using the system for clinical sample supply and tracking, all of which results in quicker data reporting to drive decision making and more effective use of resources.
Key learning objectives:
- Understand how integrated automated workflows can streamline the design, make, test, and analyze (DMTA) cycle in early-stage drug discovery.
- Learn how smaller biotech companies can successfully implement in-house compound management systems as alternatives to outsourcing.
- Identify the benefits of implementing such automated workflows, including increased data integrity, reduced data posting cycle times, decreased running costs, and faster decision-making processes.
To watch the on-demand webinar recording, complete the form on the left.
In collaboration with
